Search
2026
2025
2024
2023
-
Dec 21, 2024
YolTech Completes Dose Escalation in YOLT-201 Phase I TrialRead More
-
Oct 31, 2024
YolTech Awarded Patent for Novel Lipid Nanoparticle Technology, Strengthening In-House Delivery CapabilitiesRead More
-
Sep 23, 2024
YolTech Receives U.S. FDA ODD for YOLT-203 in Treating PH1Read More
-
Sep 04, 2024
YolTech Receives U.S. FDA RPDD for YOLT-203 in Treating PH1Read More
-
Aug 27, 2024
YolTech Announces Licensing Agreement with SalubrisRead More
